• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/17

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

17 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
Regular Insulin
Novolin-R
Humulin-R
fast acting, short acting injectable
IV use for emergencies
SC maintenance
Insulin Lispro
Humalog
faster acting, short acting injectable
"prandial" formulations
Insulin Aspart
Novolog
faster acting, short acting injectable
"prandial" formulations
NPH Insulin
Novolin-N
Humulin-N
intermediate acting
NPH = neutral protamin Hagedorn Insulin
SC injection, once in am and once in pm to maintain basal insulin level for 24 hrs.
DO NOT use for emergency IV bc not v. soluble
-basal level may be supplemented with rapid/short-acting forms
Insulin Detemir
Levemir
long acting injectable, SC
NOT soluble, not for IV use
1/2 life increases with increasing dose
potentially could be given once a day to maintain basal insulin level for 24 hrs
-basal level may be supplemented with rapid/short-acting forms
Insulin Glargine
Lantus
insulin preparation
longest acting
potentially could be given only once a day to maintain 24 hr basal insulin levels.
basal levels may be supplemented with rapid/short-acting forms
SE-1.severe hypoglycemia --> brain damage 2. immunologic rxs 3. local lipodystrophy (past) 4. weight gain
Glyburide
Diabeta
Micronase
insulin secretagogue
sulfonlyurea
stimulate release of enodgenous insulin
independent of blood glucose level
DM II only
CI=use with salicylates, antibiotics (sulfonamide), etoh, and insulin --> extreme hypoglycemia
insulin secretagogue
Glipizide
Glucotrol
insulin secretagogue
sulfonlyurea
stimulate release of enodgenous insulin
independent of blood glucose level
DM II only
Repaglinide
insulin secretagogue
meglitinide
stimulate endogenous insulin release but DEPENDENT on blood glucose level
Nateglinide
Starlix
insulin secretagogue
meglitinide
stimulate endogenous insulin release but DEPENDENT on blood glucose level
oral
Metformin
Glucophage
Fortamet
Riomet
insulin-sensitizing
oral anti-hyperglycemic
DM II
1. improves sensitivity of peripheral tissues to insulin action on glucose uptake and storage
2. decreases hepatic glucose output**primary
3. lowers arterial BP, VLDL, LDL
4. body weight not adversely affected
5. txs anovulation
SE: GI probs, lactic acidosis
CI: use with drugs that are eliminated by tubular transport systems (digoxin, morphine)
Rosiglitazone
Avandia
insulin-sensitizing
anti-hyperglycemia
1. activates nuclear receptors (PPARs) to either directly or indirectly increase insulin-mediated synthesis of new glucose transport molecules at DNA level in insulin resistant tissues.
2. leads to increased glucose uptake, decreased circulation glucose
3. "corrects" insulin resistance
4. "insulin-sparing"
5. decreases TG, BP, increases HDL
CI: CHF, edema
Pioglitazone
Actos
insulin-sensitizing
anti-hyperglycemia
1. activates nuclear receptors (PPARs) to either directly or indirectly increase insulin-mediated synthesis of new glucose transport molecules at DNA level in insulin resistant tissues.
2. leads to increased glucose uptake, decreased circulation glucose
3. "corrects" insulin resistance
4. "insulin-sparing"
5. decreases TG, BP, increases HDL
CI: CHF, edema
Acarbose
Precose
alpha-glucosidase inhibitor
taken before meals to inhibit alpha glucosidase enzymes which digest complex carbs and disaccharides --> delay postprandial glucose absorption...attenuation of postprandial increases in plasma glucose and possibly enodgenous insulin
"smoothing out" of postrprandial glucose peaks
no DIRECT effects on insulin secretion or sensitivity
oral
CI: ibs, adverse hypoglycemia w/ concurrent insulin/insulin secretagogues
Exenatide
Byetta
incretin mimetic
binds and activates human GLP-1 receptors, enhances insulin secretion, inhibits glucagon secretion, slows gastric emptying, increases sensation of satiety
SC before meals
Pramlintide
Symlin
amylin analog
slows gastric emptying, inhibits glucagon secretion, increases sensation of satiety
"smooths out peaks of blood glucose fluctuations"
SC before meals
SE: GI probs
Sitagliptin
Januvia
dipeptidyl peptidase IV inhibitor
increase insulin release and decrease glucagon release from pancreas.
DDP-IV activity is increased in many DM II pts, so inhibiting DPP-IV allows GLP-1 to do above job.
adjunctive therapy
orally 1x day
SE: URT infx, nasopharyngitis, headache
CI: sulfonylurea --> hypoglycemia